Almotriptan labels and packages

Revision as of 10:39, 5 February 2014 by Pratik Bahekar (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Almotriptan
AXERT® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Labels and Packages

The brands listed are the trademarks of their respective owners and are not the trademarks of Janssen Pharmaceuticals, Inc.

PRINCIPAL DISPLAY PANEL - 6.25 mg Tablet Carton

NDC 50458-211-01

Axert® (almotriptan malate) Tablets

equivalent to 6.25 mg almotriptan

6 tablets

Rx only

Janssen


PRINCIPAL DISPLAY PANEL - 12.5 mg Tablet Carton

NDC 50458-210-01

Axert® (almotriptan malate) Tablets

equivalent to 12.5 mg almotriptan

12 tablets

Rx only

Janssen

References

Retrieved from "https://www.wikidoc.org/index.php?title=Almotriptan_labels_and_packages&oldid=938559"